Shire Pharmacueticals in Washington, DC
Company Name: Shire Pharmacueticals
Street: 1001 Connecticut Ave NW
Postal Code: 20036
Address: 1001 Connecticut Ave NW, Washington, DC, 20036
Explore More Information
Shire: List of Products & Therapies
Shire's list of products and treatments currently on the market. Search by product name, condition or country.
All medicines for Shire Pharmaceuticals Ireland Limited
Shire UK - Welcome to Shire Pharmaceuticals UK
Welcome to ShirePharmaceuticals.co.uk To be as brave as the people we help. Shire Pharmaceuticals Limited (Shire UK) is an indirect wholly owned subsidiary of Shire ...
Shire: A Global Innovator in Specialty Biopharmaceuticals
Our purpose is to enable people with life-altering conditions to lead better lives. Explore our pioneering therapies, vision, and values at shire.com.
RxAssist - SHIRE PHARMACEUTICALS Patient Assist Program
SHIRE PHARMACEUTICALS Patient Assistance Program. Patient assistance programs (PAPs) are programs created by drug companies, such as SHIRE PHARMACEUTICALS, to offer ...
Shire Pharmaceuticals Group PLC Profile
Shire Pharmaceuticals Group PLC: Mailing Address: Hampshire International Business Park Chineham Basingstore, Hampshire RG2Y 8EP: Head Office Address:
Shire UK - Jobs at Shire - Shire Pharmaceuticals UK
Careers. Shire is a dynamic, growth company with operations worldwide. Shire enjoys the best of both worlds – a solid history of success built over the past two ...
Home | shirehaematology
Welcome to Shire Haematology. Shire is opening its doors to the wider community to provide educational material and resources in haematology.
Shire (pharmaceutical company) - Wikipedia, the free ...
Shire Plc is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the ...
Shire Share Price | SHP Stock News | Interactive Investor
SHP share price. Find the latest Shire news, trades, fundamental data, technical analysis, advanced charts and more from Interactive Investor.
Pages: 1 2